Preferred Label : Thrombin/Protease-Activated Receptor Signaling Pathway;
NCIt synonyms : Thrombin Protease-Activated Receptor Signaling Pathway;
NCIt related terms : Thrombin signaling and protease-activated receptors;
Alternative definition : BIOCARTA: Thrombin is an extracellular protease that is involved in the clotting of
blood and inflammation through its action on platelets and endothelial cells in the
vasculature and that plays a role in thrombosis and myocardial infarction. The protease
activated receptors PAR1 and PAR4 are cellular targets of thrombin signaling and members
of the G-protein coupled receptor gene family. Both of these receptors are cleaved
in their N-terminus by thrombin, unmasking a portion of the receptor sequence that
acts itself as a tethered peptide ligand that activates the receptor. The tethered
ligand that activates PAR1 is SFLLRN and the tethered ligand that activates PAR4 is
GYPGQV. Other members of the family include PAR2 which is activated by trypsin rather
than thrombin and PAR3 which seems to play a role in the activation of other PARs
but does not itself transduce a signal directly. Addition of peptide agonist exogenously
in solution can also activate PAR1, PAR2 and PAR4. PAR1 activation may be involved
in the dilation of arteries during inflammation through the action of thrombin on
endothelial cells and in platelet activation by thrombin during clotting. PAR1 and
PAR2 activation cause bronchodilation in airway and may protect against asthma. PAR
4 activation by thrombin activates platelets during clotting and mice lacking PAR4
have impaired clotting and platelets that do not respond to thrombin signaling. The
action of thrombin on PAR1 and PAR4 on platelets and endothelial cells may also contribute
to vascular permeability and inflammation. Activated PARs appear to couple primarily
through Gq-mediated stimulation of inositol phosphate metabolism and intracellular
calcium levels to activate platelets. PAR1 and PAR4 also appear to couple to multiple
G-proteins and transduce signals through more than one G-protein mediated pathway
in some circumstances. Signaling by PAR1 and PAR4 through Galpha12 pathways couples
to Rho signaling and changes in cytoskeletal structure and cell shape. Gi activation
does not appear necessary for platelet activation by PAR1 or PAR4, and platelet activation
by these receptors requires an ADP signal perhaps acting through the platelet-associated
purinergic receptor P2Y12. Gi-coupled signaling may play a role in mitogenic PAR signaling
in some settings through Map kinase activation. Activation of Rho by PAR1 can induce
cellular transformation through a Galpha12 mediated mechanism and sustained rho-dependent
phosphorylation of the myosin light chain by PAR1 contributes to cytoskeletal changes
and activation of platelets. Since the activation of PARs by protease cleavage is
irreversible the primary mechanism for down-regulation of the PAR signaling cascade
appears to be internalization and degradation of PAR receptors. (This definition may
be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_Par1Pathway;
Origin ID : C39278;
UMLS CUI : C1515419;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element